APOE and Alzheimer disease: In clinical studies, ApoE4 has widely been associated with early onset of AD, rapid progression of the disease, more severe impairment of cognitive function and altered response to AD treatment (Morris et al., 1995; Nagy et al., 1995; Wilson et al., 2002; Wu and Zhao, 2016).